- Product Details
Keywords
- ABT-263 (Navitoclax) is an orally bioavailable, small-molecule antagonist of a subset of BCl-2 (B-cell leukemia 2) family of proteins with potential antineoplastic activity. ABT-263 selectively bi...
Quick Details
- ProName: ABT-263
- CasNo: 923564-51-6
- Application: Graduate School
- Purity: >98%
- LimitNum: 0
Superiority
High purity